{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T21:31:16Z","timestamp":1770499876256,"version":"3.49.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2004,11,1]],"date-time":"2004-11-01T00:00:00Z","timestamp":1099267200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,7]],"date-time":"2016-10-07T00:00:00Z","timestamp":1475798400000},"content-version":"vor","delay-in-days":4358,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2004,11]]},"DOI":"10.1016\/j.ymthe.2004.08.006","type":"journal-article","created":{"date-parts":[[2004,10,28]],"date-time":"2004-10-28T18:44:17Z","timestamp":1098989057000},"page":"892-902","source":"Crossref","is-referenced-by-count":53,"title":["Sustained phenotypic correction of hemophilia a mice following oncoretroviral-mediated expression of a bioengineered human factor VIII gene in long-term hematopoietic repopulating cells"],"prefix":"10.1016","volume":"10","author":[{"given":"Morvarid","family":"Moayeri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Ramezani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard A.","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa S.","family":"Hawley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert G.","family":"Hawley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2004.08.006_bib1","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2174\/1566523033347417","article-title":"Development of improved factor VIII molecules and new gene transfer approaches for hemophilia A","volume":"3","author":"Saenko","year":"2003","journal-title":"Curr. Gene Ther."},{"key":"10.1016\/j.ymthe.2004.08.006_bib2","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1056\/NEJM199401063300108","article-title":"Hemophilia A","volume":"330","author":"Hoyer","year":"1994","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymthe.2004.08.006_bib3","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1016\/S0140-6736(03)13405-8","article-title":"Haemophilias A and B","volume":"361","author":"Bolton-Maggs","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.ymthe.2004.08.006_bib4","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1161\/01.RES.88.2.137","article-title":"Gene transfer as an approach to treating hemophilia","volume":"88","author":"High","year":"2001","journal-title":"Circ. Res."},{"key":"10.1016\/j.ymthe.2004.08.006_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/1566523013348904","article-title":"Progress toward vector design for hematopoietic stem cell gene therapy","volume":"1","author":"Hawley","year":"2001","journal-title":"Curr. Gene Ther."},{"key":"10.1016\/j.ymthe.2004.08.006_bib6","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1034\/j.1600-065X.2000.17802.x","article-title":"Hematopoietic stem cell gene therapy: towards clinically significant gene transfer efficiency","volume":"178","author":"Heim","year":"2000","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.ymthe.2004.08.006_bib7","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1056\/NEJMoa012616","article-title":"Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy","volume":"346","author":"Hacein-Bey-Abina","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymthe.2004.08.006_bib8","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1126\/science.1070104","article-title":"Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning","volume":"296","author":"Aiuti","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2004.08.006_bib9","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1055\/s-0038-1648444","article-title":"Toward gene therapy in haemophilia A: retrovirus-mediated transfer of a factor VIII gene into murine haematopoietic progenitor cells","volume":"67","author":"Hoeben","year":"1992","journal-title":"Thromb. Haemostasis"},{"key":"10.1016\/j.ymthe.2004.08.006_bib10","doi-asserted-by":"crossref","first-page":"5734","DOI":"10.1073\/pnas.95.10.5734","article-title":"Genetic induction of immune tolerance to human clotting factor VIII in a mouse model for hemophilia A","volume":"95","author":"Evans","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2004.08.006_bib11","first-page":"136","article-title":"Versatile retroviral vectors for potential use in gene therapy","volume":"1","author":"Hawley","year":"1994","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2004.08.006_bib12","doi-asserted-by":"crossref","first-page":"10297","DOI":"10.1073\/pnas.93.19.10297","article-title":"Thrombopoietic potential and serial repopulating ability of murine hematopoietic stem cells constitutively expressing interleukin 11","volume":"93","author":"Hawley","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2004.08.006_bib13","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1182\/blood.V92.1.83.413k09_83_92","article-title":"Sustained gene expression in retrovirally transduced, engrafting human hematopoietic stem cells and their lympho-myeloid progeny","volume":"92","author":"Cheng","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2004.08.006_bib14","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1182\/blood.V95.1.102","article-title":"Expansion of human cord blood CD34+CD38\u2212 cells in ex vivo culture during retroviral transduction without a corresponding increase in SCID repopulating cell (SRC) frequency: dissociation of SRC phenotype and function","volume":"95","author":"Dorrell","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2004.08.006_bib15","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1089\/hum.1995.6.11-1363","article-title":"Development and analysis of retroviral vectors expressing human factor VIII as a potential gene therapy for hemophilia A","volume":"6","author":"Chuah","year":"1995","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2004.08.006_bib16","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1073\/pnas.92.4.1023","article-title":"Gene therapy for hemophilia A: production of therapeutic levels of human factor VIII in vivo in mice","volume":"92","author":"Dwarki","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2004.08.006_bib17","first-page":"37","article-title":"Increased levels of spliced RNA account for augmented expression from the MFG retroviral vector in hematopoietic cells","volume":"3","author":"Krall","year":"1996","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2004.08.006_bib18","doi-asserted-by":"crossref","first-page":"24121","DOI":"10.1074\/jbc.272.39.24121","article-title":"Mutagenesis of a potential immunoglobulin-binding protein-binding site enhances secretion of coagulation factor VIII","volume":"272","author":"Swaroop","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymthe.2004.08.006_bib19","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S1525-0016(03)00073-X","article-title":"Efficient production of human factor VIII in hemophilic mice using lentiviral vectors","volume":"7","author":"Kootstra","year":"2003","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2004.08.006_bib20","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1182\/blood.V95.4.1324.004k25_1324_1329","article-title":"Prevention and treatment of factor VIII inhibitors in murine hemophilia A","volume":"95","author":"Qian","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2004.08.006_bib21","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.1182\/blood.V81.11.2925.2925","article-title":"Biochemical, immunological, and in vivo functional characterization of B-domain-deleted factor VIII","volume":"81","author":"Pittman","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2004.08.006_bib22","doi-asserted-by":"crossref","first-page":"6352","DOI":"10.1016\/S0021-9258(18)68793-9","article-title":"Synthesis, processing, and secretion of recombinant human factor VIII expressed in mammalian cells","volume":"263","author":"Kaufman","year":"1988","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymthe.2004.08.006_bib23","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1089\/15258160260194848","article-title":"Generation and characterization of human hematopoietic cell lines expressing factor VIII","volume":"11","author":"Tonn","year":"2002","journal-title":"J. Hematother. Stem Cell Res."},{"key":"10.1016\/j.ymthe.2004.08.006_bib24","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1038\/sj.gt.3302093","article-title":"Recombinant factor VIII expression in hematopoietic cells following lentiviral transduction","volume":"10","author":"Tiede","year":"2003","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2004.08.006_bib25","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1089\/104303401450942","volume":"12","author":"Kaneko","year":"2001","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2004.08.006_bib26","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1089\/10430340050015626","article-title":"Long-term persistence of human bone marrow stromal cells transduced with factor VIII-retroviral vectors and transient production of therapeutic levels of human factor VIII in nonmyeloablated immunodeficient mice","volume":"11","author":"Chuah","year":"2000","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2004.08.006_bib27","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1046\/j.1365-2516.2003.00709.x","article-title":"Bone marrow mesenchymal cells for haemophilia A gene therapy using retroviral vectors with modified long-terminal repeats","volume":"9","author":"Van Damme","year":"2003","journal-title":"Haemophilia"},{"key":"10.1016\/j.ymthe.2004.08.006_bib28","doi-asserted-by":"crossref","first-page":"5411","DOI":"10.1073\/pnas.100082597","article-title":"Preselection of retrovirally transduced bone marrow avoids subsequent stem cell gene silencing and age-dependent extinction of expression of human beta-globin in engrafted mice","volume":"97","author":"Kalberer","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2004.08.006_bib29","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1182\/blood.V75.5.1074.1074","article-title":"Retroviral-mediated transfer and amplification of a functional human factor VIII gene","volume":"75","author":"Israel","year":"1990","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2004.08.006_bib30","doi-asserted-by":"crossref","first-page":"3412","DOI":"10.1182\/blood-2003-10-3591","article-title":"Bioengineering of coagulation factor VIII for improved secretion","volume":"103","author":"Miao","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2004.08.006_bib31","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.biolcel.2003.10.001","article-title":"Integrative molecular and developmental biology of adult stem cells","volume":"95","author":"Bunting","year":"2003","journal-title":"Biol. Cell"},{"key":"10.1016\/j.ymthe.2004.08.006_bib32","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1016\/S0301-472X(99)00101-0","article-title":"Bone marrow-derived mesenchymal stem cells remain host-derived despite successful hematopoietic engraftment after allogeneic transplantation in patients with lysosomal and peroxisomal storage diseases","volume":"27","author":"Koc","year":"1999","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.ymthe.2004.08.006_bib33","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1634\/stemcells.21-5-527","article-title":"Isolation of mouse marrow mesenchymal progenitors by a novel and reliable method","volume":"21","author":"Sun","year":"2003","journal-title":"Stem Cells"},{"key":"10.1016\/j.ymthe.2004.08.006_bib34","doi-asserted-by":"crossref","first-page":"5404","DOI":"10.4049\/jimmunol.155.11.5404","article-title":"Prevention of autoimmune disease by retroviral-mediated gene therapy","volume":"155","author":"Ally","year":"1995","journal-title":"J. Immunol."},{"key":"10.1016\/j.ymthe.2004.08.006_bib35","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1089\/10430340152528156","article-title":"in vivo persistence of retrovirally transduced murine long-term repopulating cells is not limited by expression of foreign gene products in the fully or minimally myeloablated setting","volume":"12","author":"Kang","year":"2001","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2004.08.006_bib36","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1038\/sj.gt.3301826","article-title":"Myeloablation enhances engraftment of transduced murine hematopoietic cells, but does not influence long-term expression of the transgene","volume":"9","author":"Puig","year":"2002","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2004.08.006_bib37","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S1525-0016(03)00210-7","article-title":"Engraftment of retroviral EGFP-transduced bone marrow in mice prevents rejection of EGFP-transgenic skin grafts","volume":"8","author":"Andersson","year":"2003","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2004.08.006_bib38","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1006\/mthe.2000.0072","article-title":"Introduction of a xenogeneic gene via hematopoietic stem cells leads to specific tolerance in a rhesus monkey model","volume":"1","author":"Heim","year":"2000","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2004.08.006_bib39","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.ymthe.2003.08.020","article-title":"Induction of transgene-specific immunological tolerance in myeloablated nonhuman primates using lentivirally transduced CD34+ progenitor cells","volume":"8","author":"Kung","year":"2003","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2004.08.006_bib40","first-page":"4049","article-title":"Enhanced engraftment of hematopoietic progenitor cells in mice treated with granulocyte colony-stimulating factor before low-dose irradiation: implications for gene therapy","volume":"87","author":"Mardiney","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2004.08.006_bib41","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1126\/science.1088547","article-title":"LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1","volume":"302","author":"Hacein-Bey-Abina","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2004.08.006_bib42","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1056\/NEJMra032207","article-title":"Activation of the T-cell oncogene LMO2 after gene therapy for X-linked severe combined immunodeficiency","volume":"350","author":"McCormack","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymthe.2004.08.006_bib43","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1073\/pnas.84.8.2406","article-title":"Handicapped retroviral vectors efficiently transduce foreign genes into hematopoietic stem cells","volume":"84","author":"Hawley","year":"1987","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2004.08.006_bib44","doi-asserted-by":"crossref","first-page":"4717","DOI":"10.1182\/blood-2002-09-2991","article-title":"Performance- and safety-enhanced lentiviral vectors containing the human interferon-\u03b2 scaffold attachment region and the chicken \u03b2-globin insulator","volume":"101","author":"Ramezani","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2004.08.006_bib45","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/j.1749-6632.1996.tb52687.x","article-title":"Retroviral vectors for production of interleukin-12 in the bone marrow to induce a graft-versus-leukemia effect","volume":"795","author":"Hawley","year":"1996","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.ymthe.2004.08.006_bib46","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1007\/BF03401693","article-title":"Versatile retrovirus vector systems for regulated gene expression in vitro and in vivo","volume":"3","author":"Lindemann","year":"1997","journal-title":"Mol. Med."},{"key":"10.1016\/j.ymthe.2004.08.006_bib47","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/0147-619X(89)90021-8","article-title":"Comparative analysis of retroviral vector expression in mouse embryonal carcinoma cells","volume":"22","author":"Hawley","year":"1989","journal-title":"Plasmid"},{"key":"10.1016\/j.ymthe.2004.08.006_bib48","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/eji.1830180115","article-title":"Establishment of mouse cell lines which constitutively secrete large quantities of interleukin 2, 3, 4 or 5, using modified cDNA expression vectors","volume":"18","author":"Karasuyama","year":"1988","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.ymthe.2004.08.006_bib49","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0022-1759(92)90173-Q","article-title":"Increased frequency of both total and specific monoclonal antibody producing hybridomas using a fusion partner that constitutively expresses recombinant IL-6","volume":"148","author":"Harris","year":"1992","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.ymthe.2004.08.006_bib50","doi-asserted-by":"crossref","first-page":"3906","DOI":"10.1073\/pnas.96.7.3906","article-title":"Sustained correction of bleeding disorder in hemophilia B mice by gene therapy","volume":"96","author":"Wang","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2004.08.006_bib51","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1006\/mthe.2000.0190","article-title":"Lentiviral vectors for enhanced gene expression in human hematopoietic cells","volume":"2","author":"Ramezani","year":"2000","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2004.08.006_bib52","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1073\/pnas.84.5.1329","article-title":"DNA rearrangements in human follicular lymphoma can involve the 5\u2032 or the 3\u2032 region of the bcl-2 gene","volume":"84","author":"Tsujimoto","year":"1987","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001604013929?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001604013929?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,29]],"date-time":"2023-04-29T18:54:41Z","timestamp":1682794481000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001604013929"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,11]]},"references-count":52,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2004,11]]}},"alternative-id":["S1525001604013929"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2004.08.006","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2004,11]]}}}